Clinical Trial Update: Evaluation of AL-78898A in Exudative Age-Related Macular Degeneration [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating AL-78898A for wet age-related macular degeneration has completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• AL-78898A

Snippet

Sponsor: Alcon Research | Conditions: Exudative Age-Related Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2013-06-04